Literature DB >> 11278107

Anti-apoptotic effect of trans-resveratrol on paclitaxel-induced apoptosis in the human neuroblastoma SH-SY5Y cell line.

G Nicolini1, R Rigolio, M Miloso, A A Bertelli, G Tredici.   

Abstract

Paclitaxel, an anticancer drug, induces apoptosis in human neuroblastoma cell line SH-SY5Y. The addition of trans-resveratrol, a natural antioxidant present in grapes and red wine, to SH-SY5Y cultures exposed to paclitaxel significantly reduces cellular death. The neuroprotective action of trans-resveratrol is due neither to its antioxidant capacity nor to interference with the polymerization of tubulin induced by paclitaxel. However, trans-resveratrol is able to inhibit the activation of caspase 7 and degradation of poly-(ADP-ribose)-polymerase which occur in SH-SY5Y exposed to paclitaxel. Resveratrol, therefore, exerts its anti-apoptotic effect by modulating the signal pathways that commit these neuronal-like cells to apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278107     DOI: 10.1016/s0304-3940(01)01654-8

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  25 in total

1.  Resveratrol attenuates early pyramidal neuron excitability impairment and death in acute rat hippocampal slices caused by oxygen-glucose deprivation.

Authors:  Huaqiu Zhang; Gary P Schools; Ting Lei; Wei Wang; Harold K Kimelberg; Min Zhou
Journal:  Exp Neurol       Date:  2008-04-08       Impact factor: 5.330

Review 2.  Chemosensitization of tumors by resveratrol.

Authors:  Subash C Gupta; Ramaswamy Kannappan; Simone Reuter; Ji Hye Kim; Bharat B Aggarwal
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 3.  Mitochondrial function in hypoxic ischemic injury and influence of aging.

Authors:  P Benson Ham; Raghavan Raju
Journal:  Prog Neurobiol       Date:  2016-06-16       Impact factor: 11.685

4.  The anti-tumor effect of resveratrol alone or in combination with immunotherapy in a neuroblastoma model.

Authors:  Brenda L Soto; Jacquelyn A Hank; Tyler J Van De Voort; Lalita Subramanian; Arthur S Polans; Alexander L Rakhmilevich; Richard K Yang; Songwong Seo; KyungMann Kim; Ralph A Reisfeld; Stephen D Gillies; Paul M Sondel
Journal:  Cancer Immunol Immunother       Date:  2011-02-22       Impact factor: 6.968

Review 5.  Promise of resveratrol for easing status epilepticus and epilepsy.

Authors:  Ashok K Shetty
Journal:  Pharmacol Ther       Date:  2011-04-28       Impact factor: 12.310

6.  Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity.

Authors:  Jürgen Sonnemann; Melanie Kahl; Priyanka M Siranjeevi; Annelie Blumrich; Lisa Blümel; Sabine Becker; Susan Wittig; René Winkler; Oliver H Krämer; James F Beck
Journal:  J Cancer Res Clin Oncol       Date:  2015-06-09       Impact factor: 4.553

Review 7.  Resveratrol Protects from Toxin-Induced Parkinsonism: Plethora of Proofs Hitherto Petty Translational Value.

Authors:  Mohd Sami Ur Rasheed; Manish Kumar Tripathi; Abhishek Kumar Mishra; Saurabh Shukla; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2015-02-18       Impact factor: 5.590

Review 8.  Progress in neuroprotective strategies for preventing epilepsy.

Authors:  Munjal M Acharya; Bharathi Hattiangady; Ashok K Shetty
Journal:  Prog Neurobiol       Date:  2007-12-08       Impact factor: 11.685

9.  Inhibition of citrinin-induced apoptotic biochemical signaling in human hepatoma G2 cells by resveratrol.

Authors:  Chia-Chi Chen; Wen-Hsiung Chan
Journal:  Int J Mol Sci       Date:  2009-07-29       Impact factor: 6.208

10.  Protective effects of acetyl-L-carnitine on cisplatin cytotoxicity and oxidative stress in neuroblastoma.

Authors:  Zekiye Sultan Altun; Dilek Güneş; Safiye Aktaş; Zübeyde Erbayraktar; Zübeyde Erbayrktar; Nur Olgun
Journal:  Neurochem Res       Date:  2009-10-23       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.